Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.

Guixé Muntet, Sergi; Zhu, Chang-Peng; Xie, Wei-Fen; Gracia Sancho, Jorge (2020). Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & therapeutics, 215, p. 107626. Elsevier 10.1016/j.pharmthera.2020.107626

Text
1-s2.0-S016372582030156X-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (1MB) | Request a copy

Portal hypertension (PH) is the most common non-neoplastic complication of chronic liver disease, determining clinical complications that lead to death or liver transplantation. PH results from increased resistance to portal blood flow through the cirrhotic liver, which is due to hepatic fibrosis and microcirculatory dysfunction. The present review focuses on the pathophysiology of fibrosis and PH, describes currently used treatments, and critically discusses potential therapeutic options.

Item Type:	Journal Article (Review Article)
Division/Institute:	04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
UniBE Contributor:	Guixé Muntet, Sergi, Gracia Sancho, Jorge Sergio
Subjects:	600 Technology > 610 Medicine & health
ISSN:	0163-7258
Publisher:	Elsevier
Language:	English
Submitter:	Thi Thao Anh Pham
Date Deposited:	09 Dec 2020 18:32
Last Modified:	05 Dec 2022 15:42
Publisher DOI:	10.1016/j.pharmthera.2020.107626
PubMed ID:	32659305
Uncontrolled Keywords:	Cirrhosis Hepatic hemodynamic Hepatic stellate cells Liver microcirculation Portal pressure
BORIS DOI:	10.7892/boris.148516
URI:	https://boris.unibe.ch/id/eprint/148516

Actions (login required)

Edit item

Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.

Interest & Impact

Downloads

Citations

Search

Services

Actions (login required)

Item Type:

Division/Institute:

UniBE Contributor:

Subjects:

ISSN:

Publisher:

Language:

Submitter:

Date Deposited:

Last Modified:

Publisher DOI:

PubMed ID:

Uncontrolled Keywords:

BORIS DOI:

URI:

Actions (login required)